Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 11.66B | 12.16B | 11.96B | 12.03B | 12.07B | 12.18B |
Gross Profit | 11.66B | 12.35B | 11.96B | 11.93B | 11.86B | 9.18B |
EBITDA | -504.00M | -578.00M | 1.72B | 1.76B | 1.43B | -1.07B |
Net Income | -1.25B | -1.25B | 866.00M | 868.00M | 826.00M | -1.72B |
Balance Sheet | ||||||
Total Assets | 805.10B | 805.10B | 828.95B | 839.88B | 842.25B | 825.75B |
Cash, Cash Equivalents and Short-Term Investments | 55.58B | 55.58B | 79.11B | 76.26B | 90.61B | 92.13B |
Total Debt | 2.11B | 2.11B | 2.13B | 47.63B | 35.59B | 29.34B |
Total Liabilities | 781.03B | 781.03B | 803.87B | 815.60B | 814.89B | 796.11B |
Stockholders Equity | 23.91B | 23.91B | 24.94B | 24.13B | 27.22B | 29.52B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 6.03B | 10.96B | -7.67B | 12.79B | 38.69B |
Operating Cash Flow | 0.00 | 7.31B | 11.59B | -7.43B | 13.18B | 39.07B |
Investing Cash Flow | 0.00 | -3.38B | 1.49B | -6.45B | -14.22B | -23.08B |
Financing Cash Flow | 0.00 | -20.80B | -140.00M | -140.00M | -1.00M | -113.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | ¥10.14B | 7.15 | 4.00% | 2.44% | 10.20% | ||
73 Outperform | ¥12.19B | 6.94 | 1.10% | 2.20% | ― | ||
72 Outperform | ¥12.89B | 11.15 | 3.68% | 7.67% | -26.27% | ||
68 Neutral | $17.80B | 11.87 | 10.23% | 3.74% | 9.69% | 1.18% | |
65 Neutral | ¥9.39B | 25.08 | 2.70% | 3.73% | -78.83% | ||
61 Neutral | ¥9.14B | 8.74 | 2.97% | -9.75% | 81.65% | ||
57 Neutral | ¥8.58B | ― | 2.03% | 2.60% | -246.98% |